Some reports have suggested that miR-26b can suppress NF-κB signaling and thereby sensitize hepatocellular carcinoma cells to the doxorubicin-induced apoptosis by inhibiting the expression of TAK1 and TAB3 [41]. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.